secwatch.observer — SEC 8-K summary
======================================

Issuer:     TELA Bio, Inc. (TELA)
CIK:        0001561921
Form:       8-K
Filed at:   2021-09-27T23:59:59+00:00
Accession:  0001104659-21-119817
Event type: leadership
Sentiment:  neutral
Materiality: 0.50
Item codes: 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

TELA Bio appoints Roberto Cuca as CFO and COO effective September 27, 2021
--------------------------------------------------------------------------

- Roberto Cuca appointed CFO and COO, effective 9/27/21; succeeds Megan Smeykal as principal financial officer.
- Employment agreement: $425k base salary, 50% target bonus, and inducement option for 144k shares at $13.31.
- Option vests 25% on 1st anniversary, 75% over 36 months; severance includes 9-12 months base salary.
- Cuca previously CFO of OraSure Technologies (Jun 2018-Sep 2021) and Trevena (Sep 2013-May 2018).
- Inducement grant complies with Nasdaq Rule 5635(c)(4).

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1561921/000110465921119817/0001104659-21-119817-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1561921/000110465921119817/tm2128539d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-21-119817

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer